Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Jacobs Wins New Contract – Analyst Blog

Zacks Market Commentaries (October 7th, 2009) Writes:
Yesterday, Jacobs Engineering Group Inc. (JEC) received a contract from the Stanford University Medical Center in Palo Alto, Calif. According to the contract Jacobs will provide program and construction management services for the New Stanford Hospital and Lucile Packard Children's Hospital Expansion Projects. However, the contract value was not disclosed.   Recently, the company also received a contract from Abu Dhabi Polymers Company (Borouge) to develop front-end engineering and design (FEED) for a section of the "Borouge 3" project, a grassroots polypropylene/polyethylene facility in Abu Dhabi in the United Arab Emirates.   With annual revenues exceeding $12 billion, Jacobs’ is one of the world's largest and most diverse providers of technical, professional and construction services. Its major competitors are Foster Wheeler AG (FWLT) and Fluor Corp. (FLR).   The company’s diversification in terms of markets, geography and services will continue to facilitate future growth. Moreover, Jacobs’ ...

XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN, DrStockPick.com Stock Report!

Dr. Stock Pick (September 28th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday September 28, 2009

DrStockPick.com Stock Report!

XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN

**************************************************************

XRX, Xerox Corp.

XRX engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.

XRX said Monday it will buy Affiliated Computer Services Inc. for $6.4 billion in cash and stock to create a $22 billion business that combines XRX’s copiers, printers and document management services with the “business process outsourcing” of Dallas-based ACS., joining the expensive race among technology companies to broaden their offerings.

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in

...
Tags for this Post:
Abbott Laboratories, ABT, adult and pediatric pharmaceuticals, advertisement services, advertising services, Affiliated Computer Services Inc., ALS, anemia, anesthesia products, ankylosing spondylitis;, anti-infectives, Argentina, Beijing, beverage, bipolar disorder, Breast Cancer, broker, cable services;, cancer, Cavitation Technologies Inc., ceo, Chair and Keynote Speaker, chemical industries, chemicals maker;, chief scientific officer, China, Chinese Ministry of Commerce, Comcast Corporation;, communication products, communications products, Congress, Consorteum Holdings Inc.;, credit card transaction processing, Crown Equity Holdings Inc.;, CSRH, Cupertino;, Dallas, diagnostic tests, digital media, digital out-of-home advertising networks, document equipment, document management services, Dow Chemical, Dr Stock Pick, dyslipidemia;, electronic transaction processing;, endometriosis, epilepsy, equity trader, Fda, Financial Services, Focus Media Holding Ltd., food, health care products, healthcare, HIV infection, Houston, hypothyroidism, International Congress, Investing Lessons, Ira Goldknopf, Latin America, leader in the development, Los Altos, migraines;, Milpitas, mobile handset advertising, Mountain View, neurodegenerative disease;, North America, obesity, out-of-home advertising network, outdated technologies, Palo Alto;, payment processing industry, Pharmaceutical, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, precocious puberty, president, President & COO, professional investment analyst and consultant, Prostate Cancer, psoriasis, psoriatic arthritis;, Quent Rickerby;, Rheumatoid Arthritis, Ricoh XR-X 3PF Film Camera;, Roman Gordon, San Francisco, San Rafael, Santa Clara, Saratoga, secondary hyperparathyroidism, SINA Corporation;, Solvay, stock featured on our site;, Stock Pick, Stocks to Watch, Sunnyvale, Technology, technology solutions, Texas, transaction processing industries;, transactional processing systems;, United States, USD, uterine fibroids;, Vacaville, vegetable oil refining, www.alsbio.com, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.dow.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com, Xerox Corp.;, XRX

GENZ, PWRM, STEM, CTIC, PFE, DrStockPick.com Stock Report!

Dr. Stock Pick (September 23rd, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Wednesday September 23, 2009

DrStockPick.com Stock Report!

GENZ, PWRM, STEM, CTIC, PFE

**************************************************************

GENZ, Genzyme Corporation

GENZ is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 11,000 employees in locations spanning the globe and 2008 revenues of $4.6 billion.

GENZ provided an update on its progress to restore supplies of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) for patients worldwide and revised its 2009 revenue guidance for these products. GENZ is now approximately half-way through the anticipated shortage period

...
Tags for this Post:
advertisement services, Allston Landing manufacturing facility, ALS, Beijing, Biopharmaceutical, biopharmaceutical company taking new approaches, Breast Cancer, broker, California, Cambridge, cancer, Cell Therapeutics Inc., Chair and Keynote Speaker, chief scientific officer, China, Congress, Crown Equity Holdings Inc.;, CTIC;, diagnostic tests, Dr Stock Pick, drug development, drug screening, equity trader, Fda, Genzyme Corporation, Houston, Human Rights Campaign Foundation, International Congress, Investing Lessons, Ira Goldknopf, LGBT, Lymphoma, neurodegenerative disease;, oncology products;, Palo Alto;, Pfizer Inc, Pharmaceutical, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, professional investment analyst and consultant, StemCells Inc., stock featured on our site;, Stock Pick, Stocks to Watch, Texas, United Kingdom, United States, USD, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

VARI, Varian, Inc. PennyOmega.com HOT Stock ALERT! 7/27/09

Penny Omega (July 27th, 2009) Writes:

PennyOmega.com HOT Stock ALERT!

PennyOmega.com Hot Stock News & Alerts!

signup3m

 

Monday July 27, 2009

PennyOmega.com HOT Stock ALERT!

**************************************************************

SANTA CLARA, Calif. & PALO ALTO, Calif.–(CRWENEWS WIRE)– Agilent Technologies Inc. (NYSE:A) and Varian, Inc. (NasdaqGS:VARI) today announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a leading worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications. Agilent will pay $52 cash per share of common stock for Varian in a transaction that represents a premium of approximately 35% to Varian’s closing price on July 24, 2009. Both Agilent’s and Varian’s Board of Directors have unanimously approved the all-cash offer.

The acquisition broadens Agilent’s applications

...
Tags for this Post:
+1 (650) 424-5471, Adrian Dillon, Agilent of Varian, Agilent Technologies Inc.;, analytical solutions, application-focused solutions, applied market applications, Asia Pacific, Bill Sullivan;, Board;, broadest product, California, Chairman and Chief Executive Officer, chemical analysis, clear market leader, Cobalt Acquisition Corp., corporate Web site, electronics, energy, Energy Industry, Europe, executive vice president and Chief Financial Officer, food, Food Safety, Garry Rogerson, gas chromatography, gas chromatography/mass spectrometry, Governor, imaging, independent advisors, leader, Market Commentary, Nasdaq 100, North America, our Board, Palo Alto;, PennyOmega.com, president and chief executive officer, Santa Clara, Securities And Exchange Commission, spectroscopy, stock featured on our site;, Stocks to Watch, Supply Chain, technology base, USD, vacuum, vacuum products, vacuum technologies, Varian Inc., www.agilent.com, www.sec.gov, www.varianinc.com

DrStockPick.com HOT Stock Alert! Monday July 27, 2009, VARI, Varian, Inc

Dr. Stock Pick (July 27th, 2009) Writes:

DrStockPick.com HOT Stock Alert!

Monday July 27, 2009

signup3m

**************************************************************

SANTA CLARA, Calif. & PALO ALTO, Calif.–(CRWENEWS WIRE)– Agilent Technologies Inc. (NYSE:A) and Varian, Inc. (NasdaqGS:VARI) today announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a leading worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications. Agilent will pay $52 cash per share of common stock for Varian in a transaction that represents a premium of approximately 35% to Varian’s closing price on July 24, 2009. Both Agilent’s and Varian’s Board of Directors have unanimously approved the all-cash offer.

The acquisition broadens Agilent’s applications and solutions offerings in Life Sciences, Environmental, and Energy

...
Tags for this Post:
+1 (650) 424-5471, Adrian Dillon, Agilent of Varian, Agilent Technologies Inc.;, analytical solutions, application-focused solutions, applied market applications, Asia Pacific, Bill Sullivan;, Board;, broadest product, California, Chairman and Chief Executive Officer, chemical analysis, clear market leader, Cobalt Acquisition Corp., corporate Web site, Dr Stock Pick, electronics, energy, Energy Industry, Europe, executive vice president and Chief Financial Officer, food, Food Safety, Garry Rogerson, gas chromatography, gas chromatography/mass spectrometry, Governor, imaging, independent advisors, leader, Market Commentary, Nasdaq 100, North America, our Board, Palo Alto;, president and chief executive officer, Santa Clara, Securities And Exchange Commission, spectroscopy, Stocks to Watch, Supply Chain, technology base, USD, vacuum, vacuum products, vacuum technologies, Varian Inc., www.agilent.com, www.sec.gov, www.varianinc.com

QD Soleil, subsidiary of Nanostart-held Nanosys, expands leadership team with world-class nanotechnology leaders

Dawn Van Zant (June 30th, 2009) Writes:
Frankfurt / Palo Alto, Calif. - June 30, 2009 - QD Soleil, a division of Nanostart held Nanosys, Inc., announced the expansion of its leadership and advisory team including the addition of four exceptional thought leaders in the use of nanotechnology for solar energy applications.

Why Will You Think Of Land Banking to Be Profitable Mode of Investment?

Investment Education Staff (June 1st, 2009) Writes:

by Arick Neilson

Different investment policies might get you confused as to where you will invest. And especially, at the time of economic recession, it becomes crucial to arrive at an informed decision.

Investing in real estate has often been considered as lucrative, safe and more rewarding. Other financial sectors of land banking can be wise investment option you can choose. And here comes the question of finding right investment firm or company that you can trust in.

For the investment solutions and services, you can think of ACE Capital Group which is established as well as trusted real estate investment firm. They have proved themselves to be more profitable during the economic depression.

Why Will You Think Of Land Banking to Be Profitable Mode of Investment?

The prices of investing in land will never decrease and therefore, many financial experts recommend investing in it.

Investing in land, which is called Land Banking, is …

Facebook Gets Russian Touch – Zacks Tale of the Tape

Zacks Market Commentaries (May 26th, 2009) Writes:

Facebook Inc. said it received $200 million in investment from a Russian Internet firm on Tuesday, valuing the world's largest social-networking website at $10 billion and helping it meet costs resulting from its surging popularity even during the recession.

The deal comes 2 years after the company sold a 1.6% stake to Microsoft Corp. (MSFT) for $240 million, valuing itself at approximately $15 billion, before the economic crisis came to the fore. Since then, Facebook has struggled to find investors to help it support costs of servicing more than 200 million global members.

Digital Sky Technologies (DST), led by Russian entrepreneur Yuri Milner, will get a 1.96% stake in the Palo Alto, California-based company in exchange for preferred stock but would not be represented on its board.

"A number of firms approached us, but DST stood out because of the global perspective they bring --

...

Nanostart holding Nanosys launches new solar photovoltaic division, QD Soleil

Dawn Van Zant (May 13th, 2009) Writes:
Frankfurt / Palo Alto, CA - May 13, 2009 - Nanostart holding Nanosys recently announced the creation of QD SoleilT, a wholly owned division focused on the use of its proprietary nanotechnology in solar panel cell designs.

CNS Response, Inc. (CNSO.OB) Awarded Third U.S. Patent Targeting the Development of New Indications for Existing Drugs

QualityStocks (March 23rd, 2009) Writes:

CNS Response, Inc. announced that it has received a patent from the U.S. Patent and Trademark Office. The patent, numbered 7,489,964 and titled “Electroencephalography Based Systems and Methods for Selecting Therapies and Predicting Outcomes”, extends application of rEEG® technology to novel methods that can expand indications for CNS pharmaceuticals.

“One of the most compelling opportunities in pharmaceutical marketing is the ability to expand new indications for already approved medications,” commented CNS Response CEO Len Brandt. “With the successful completion of our multisite study for the treatment of resistant depression, I believe we will have demonstrated the utility of the rEEG technology not only to physicians treating behavioral illness, but also to the pharmaceutical industry including ways described in this patent.”

The awarded patent presents novel use of CNS Response protected methodology for development of new indications of FDA approved pharmaceuticals when using an EEG computer analysis. One demonstration of patient

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.